Ionis Pharmaceuticals Inc. Common Stock vs SailPoint Inc. Common Stock — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B), while SailPoint Inc. Common Stock trades at $19.18 (market cap $11.06B). The key difference: SailPoint Inc. Common Stock is the larger of the two by market cap, and SailPoint Inc. Common Stock is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and SailPoint Inc. Common Stock for 0 Days on average.
| IONS | SAIL | |
|---|---|---|
Market Cap | $7.04B | $11.06B |
Volume | 2,977,440 | 3,269,663 |
Sector | Health | Technology |
52-Week High | $86.50 | $22.85 |
52-Week Low | $42.38 | $10.49 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.60B | $10.76B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →SailPoint, Inc. develops identity security software that helps enterprises manage and govern access to applications and data across users, machines, and AI agents. Its unified identity security platform combines automation and intelligence to control identity-related risk at scale for large organizations.
Read more on SAIL →